The International Contrast Ultrasound Society (ICUS)
ICUS is pleased to note that the Mexican Federal Commission for Protection Against Sanitary Risk (COFEPRIS) has approved the contrast agent SonoVue in Mexico for use in echocardiography and Doppler ultrasonography. SonoVue is produced by Bracco and will be marketed in Mexico by Justesa Imagen Mexicana, S.A. de C.V.
ICUS applauds this action. We have long advocated for broader acceptance and appropriate use of ultrasound contrast agents, which have strong safety profiles and reduce overall health care costs without exposing patients to ionizing radiation.